Loading...

ARMP ARMATA PHARMACEUTICALS INC Capital Structure Changes 8-K Filing

RMT

RMP

ARMATA PHARMACEUTICALS INC

(ARMP)

2025 8-K

New Stock Offering

Financial Results Released

Positive Study Results

Corporate Presentation

Product Expansion

Financial Statements

Market Expansion

Annual Meeting Notice

Financial Results

Management Change

Management Changes

Financial Results

Study Enrollment Complete

Management Change

Management Change

Management Appointment

Financial Results

Amendment to Employment Agr...

Annual Meeting of Shareholders

Earnings Reports

Annual Meeting Announcement

Financial Results Announcement

Credit Agreement with Innov...

Promotion of Richard Rychlik

Earnings Reports

Annual Meeting Announcement

Earnings Reports

Management Changes

External Links:

On March 12, 2025, Armata Pharmaceuticals entered into a $10 million secured loan agreement with Innoviva at a 14% interest rate, maturing on March 12, 2026, and amended previous credit agreements to extend their maturity dates to the same date.

AI Assistant

ARMATA PHARMACEUTICALS INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.